100% Quality Guarantee
PhD-Level Technical Support
Key Features

TSHR Biosimilar (M22) Antibody (HDBS0073)

SKU HDBS0073
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein TSHR
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

TSHR Biosimilar (M22) Antibody (HDBS0073)

The Anti-TSHR M22 Antibody (HDBS0073) is a highly specific monoclonal antibody designed for research involving the Thyroid-Stimulating Hormone Receptor (TSHR). This antibody is raised in mice and is validated for use in various applications, including immunohistochemistry and flow cytometry, making it a versatile tool for studying TSHR expression and function.The TSHR is a key regulator of thyroid function and plays a crucial role in the control of metabolism and energy balance. Dysregulation of TSHR signaling has been implicated in thyroid disorders such as hyperthyroidism and Graves' disease, making the Anti-TSHR M22 Antibody a valuable tool for investigating these conditions.

With its high specificity and sensitivity, this antibody enables accurate detection and analysis of TSHR expression in different tissues and cell types. Its use in research can provide insights into the mechanisms underlying thyroid dysregulation and potentially contribute to the development of novel therapeutic strategies for thyroid-related disorders.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose